To decipher the impact of ARID1B cellular protein abundance in tumor malignancy, we examined the expression of ARID1B in a panel of breast cancer cell lines, including mammary gland epithelial, luminal, HER2+ and TNBC. This evidence concerns the gene ERBB2 and breast cancer.